BIOMAT Database Logo BIOMAT Database Logo

Studies of mechanisms of chemical radiation protection in vivo. I. 5-Hydroxytryptamine in relation to effect of antimetabolites, antagonists and releasing agents. 1961

H A VAN DEN BRENK, and M HAAS

UI MeSH Term Description Entries
D011835 Radiation Protection Methods and practices adopted to protect against RADIATION. Protection, Radiation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000963 Antimetabolites Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) Antimetabolite
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine

Related Publications

H A VAN DEN BRENK, and M HAAS
5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
February 1990, European journal of pharmacology,
H A VAN DEN BRENK, and M HAAS
[Studies on biological radiation protection. 81. On the metabolism of injected 5-hydroxytrypt1 of injected 5-hydroxytryptamine in mice with regard to chemical radiation protectin].
November 1967, Strahlentherapie,
H A VAN DEN BRENK, and M HAAS
Studies of mechanisms of chemical radiation protection in vivo. II. Effect of high pressure oxygen on radioprotection in vivo and its relationship to 'oxygen poisoining'.
February 1962, International journal of radiation biology and related studies in physics, chemistry, and medicine,
H A VAN DEN BRENK, and M HAAS
Quantitative studies of antagonists for 5-hydroxytryptamine.
January 1955, Quarterly journal of experimental physiology and cognate medical sciences,
H A VAN DEN BRENK, and M HAAS
Distribution of 5-hydroxytryptamine-2-14C in mice with respect to chemical protection against ionizing radiation.
January 1966, International journal of radiation biology and related studies in physics, chemistry, and medicine,
H A VAN DEN BRENK, and M HAAS
[Significance of glutathione in radiation effect studies and chemical radiation protection].
June 1972, Strahlentherapie,
H A VAN DEN BRENK, and M HAAS
[Studies on a biological radiation protection. XXXIII. Further studies on the mechanism of action of 5-hydroxytryptamine in radiation protection experiment].
December 1959, Strahlentherapie,
H A VAN DEN BRENK, and M HAAS
5-Hydroxytryptamine and 5-hydroxytryptamine-3 receptor antagonists.
January 1991, Scandinavian journal of gastroenterology. Supplement,
H A VAN DEN BRENK, and M HAAS
[Studies on a biological radiation protection. XXX. Radiation protective effects of 5-hydroxytryptamine in animal experiments].
February 1959, Strahlentherapie,
H A VAN DEN BRENK, and M HAAS
[Studies on a biological radiation protection. XXXI. On the mechanism of action of 5-hydroxytryptamine in a radiation protection experiment].
August 1959, Strahlentherapie,
Copied contents to your clipboard!